Zidian Xie1, Deborah J Ossip2, Irfan Rahman3, Dongmei Li1. 1. Department of Clinical & Translational Research, University of Rochester Medical Center, Rochester, NY. 2. Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY. 3. Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY.
Abstract
INTRODUCTION: Electronic cigarette (e-cigarette) use (vaping) has increased in recent years. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death associated with smoking. AIMS AND METHODS: Based on 2016 and 2017 Behavioral Risk Factor Surveillance System national survey data on 891 242 adult participants who indicated their smoking and vaping status, the cross-sectional association of vaping with self-reported COPD diagnosis was investigated, using univariable and multivariable weighted logistic regression models. RESULTS: Compared to never users, while dual users showed the highest association with self-reported COPD diagnosis (adjusted odds ratio [aOR] = 4.39; 95% confidence interval [CI] = 3.98 to 4.85), current vapers who were either ex-smokers or never smoked showed significantly higher association with self-reported COPD diagnosis (aOR = 3.24; 95% CI = 2.78 to 3.78 and aOR = 1.47; 95% CI = 1.01 to 2.12, respectively). Current vapers who were ex-smokers showed higher association with self-reported COPD diagnosis than ex-smokers who do not vape (aOR = 1.27; 95% CI = 1.09 to 1.48). Dual users showed higher association with self-reported COPD diagnosis than current smokers who do not vape (aOR = 1.16; 95% CI = 1.05 to 1.27). Ex-smokers showed significantly less association with self-reported COPD diagnosis (aOR = 0.67; 95% CI = 0.64 to 0.71) than current smokers. Current vapers who were either ex-smokers or never smoked had less association with self-reported COPD diagnosis compared to current smokers, with aOR = 0.85 (95% CI = 0.73 to 0.99) and aOR = 0.39 (95% CI = 0.27 to 0.56). CONCLUSIONS: Vaping is significantly associated with self-reported COPD diagnosis in adults, even among vapers who never smoked. Whether there is a benefit for COPD of switching from smoking to vaping requires study of the long-term effects of vaping. IMPLICATIONS: With the increase of e-cigarette use in recent years, the health effects of e-cigarettes need to be investigated. While several studies have examined the association of vaping with respiratory symptoms among adolescents, little is known about the association of vaping with susceptibility to COPD among US adults. Using cross-sectional national survey data in adults, our study showed that vaping was significantly associated with self-reported COPD diagnosis. Although our data did not establish the causal relationship between vaping and self-reported COPD diagnosis, this study raises concerns about the observed association between vaping and self-reported COPD diagnosis.
INTRODUCTION: Electronic cigarette (e-cigarette) use (vaping) has increased in recent years. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death associated with smoking. AIMS AND METHODS: Based on 2016 and 2017 Behavioral Risk Factor Surveillance System national survey data on 891 242 adult participants who indicated their smoking and vaping status, the cross-sectional association of vaping with self-reported COPD diagnosis was investigated, using univariable and multivariable weighted logistic regression models. RESULTS: Compared to never users, while dual users showed the highest association with self-reported COPD diagnosis (adjusted odds ratio [aOR] = 4.39; 95% confidence interval [CI] = 3.98 to 4.85), current vapers who were either ex-smokers or never smoked showed significantly higher association with self-reported COPD diagnosis (aOR = 3.24; 95% CI = 2.78 to 3.78 and aOR = 1.47; 95% CI = 1.01 to 2.12, respectively). Current vapers who were ex-smokers showed higher association with self-reported COPD diagnosis than ex-smokers who do not vape (aOR = 1.27; 95% CI = 1.09 to 1.48). Dual users showed higher association with self-reported COPD diagnosis than current smokers who do not vape (aOR = 1.16; 95% CI = 1.05 to 1.27). Ex-smokers showed significantly less association with self-reported COPD diagnosis (aOR = 0.67; 95% CI = 0.64 to 0.71) than current smokers. Current vapers who were either ex-smokers or never smoked had less association with self-reported COPD diagnosis compared to current smokers, with aOR = 0.85 (95% CI = 0.73 to 0.99) and aOR = 0.39 (95% CI = 0.27 to 0.56). CONCLUSIONS: Vaping is significantly associated with self-reported COPD diagnosis in adults, even among vapers who never smoked. Whether there is a benefit for COPD of switching from smoking to vaping requires study of the long-term effects of vaping. IMPLICATIONS: With the increase of e-cigarette use in recent years, the health effects of e-cigarettes need to be investigated. While several studies have examined the association of vaping with respiratory symptoms among adolescents, little is known about the association of vaping with susceptibility to COPD among US adults. Using cross-sectional national survey data in adults, our study showed that vaping was significantly associated with self-reported COPD diagnosis. Although our data did not establish the causal relationship between vaping and self-reported COPD diagnosis, this study raises concerns about the observed association between vaping and self-reported COPD diagnosis.
Authors: Catherine Ann Hess; Pablo Olmedo; Ana Navas-Acien; Walter Goessler; Joanna E Cohen; Ana Maria Rule Journal: Environ Res Date: 2016-10-28 Impact factor: 6.498
Authors: Lion Shahab; Maciej L Goniewicz; Benjamin C Blount; Jamie Brown; Ann McNeill; K Udeni Alwis; June Feng; Lanqing Wang; Robert West Journal: Ann Intern Med Date: 2017-02-07 Impact factor: 25.391
Authors: Stefanie Scheffler; Hauke Dieken; Olaf Krischenowski; Christine Förster; Detlev Branscheid; Michaela Aufderheide Journal: Int J Environ Res Public Health Date: 2015-04-08 Impact factor: 3.390
Authors: Tom Liu; Thomas J Deiss; Matthew W Lippi; Alejandra Jauregui; Kathryn Vessel; Serena Ke; Annika Belzer; Hanjing Zhuo; Kirsten N Kangelaris; Antonio D Gomez; Michael A Matthay; Kathleen D Liu; Carolyn S Calfee Journal: Int J Environ Res Public Health Date: 2020-11-24 Impact factor: 3.390
Authors: Mohammed Nasser Alhajj; Sadeq Ali Al-Maweri; Morenike O Folayan; Esam Halboub; Yousef Khader; Ridwaan Omar; Abdullah G Amran; Ola B Al-Batayneh; Asja Celebić; Sanja Persic; Humeyra Kocaelli; Firas Suleyman; Abdulaziz A Alkheraif; Darshan D Divakar; Abdulbaset A Mufadhal; Mohammed A Al-Wesabi; Wadhah A Alhajj; Mokhtar A Aldumaini; Saadika Khan; Thiyezen A Al-Dhelai; Ahmed Shaher Alqahtani; Ali H Murad; Joseph E Makzoumé; Shivani Kohli; Tareq A Ziyad Journal: BMC Oral Health Date: 2022-01-26 Impact factor: 2.757
Authors: Hangchuan Shi; Zahíra Quiñones Tavárez; Zidian Xie; Liane M Schneller; Daniel P Croft; Maciej L Goniewicz; Scott McIntosh; Richard J O'Connor; Deborah J Ossip; Irfan Rahman; Dongmei Li Journal: Tob Induc Dis Date: 2020-10-01 Impact factor: 2.600